Literature DB >> 22542283

Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.

Yumiko Yamano1, Kazuhito Tsuboi, Yuki Hozaki, Kiyohiro Takahashi, Xing-Hua Jin, Natsuo Ueda, Akimori Wada.   

Abstract

N-Acylethanolamines (NAEs) including N-arachidonoylethanolamine (anandamide) and N-palmitoylethanolamine are endogenous lipid mediators. These molecules are degraded to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH) or NAE-hydrolyzing acid amidase (NAAA). Lipophilic amines, especially pentadecylamine (2c) and tridecyl 2-aminoacetate (11b), were found to exhibit potent NAAA inhibitory activities (IC(50)=5.7 and 11.8μM), with much weaker effects on FAAH. These simple structures would provide a scaffold for further improvement in NAAA inhibitory activity.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542283     DOI: 10.1016/j.bmc.2012.03.065

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

1.  Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.

Authors:  Mireille Alhouayek; Linda Rankin; Sandra Gouveia-Figueira; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2018-02-05       Impact factor: 8.739

2.  2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease.

Authors:  Marika Cordaro; Rosalba Siracusa; Rosalia Crupi; Daniela Impellizzeri; Alessio Filippo Peritore; Ramona D'Amico; Enrico Gugliandolo; Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2018-04-14       Impact factor: 5.590

3.  Activity-Based Probe for N-Acylethanolamine Acid Amidase.

Authors:  Elisa Romeo; Stefano Ponzano; Andrea Armirotti; Maria Summa; Fabio Bertozzi; Gianpiero Garau; Tiziano Bandiera; Daniele Piomelli
Journal:  ACS Chem Biol       Date:  2015-06-23       Impact factor: 5.100

Review 4.  Advances in the discovery of N-acylethanolamine acid amidase inhibitors.

Authors:  Tiziano Bandiera; Stefano Ponzano; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2014-05-04       Impact factor: 7.658

Review 5.  N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.

Authors:  Stephen D Skaper; Laura Facci; Massimo Barbierato; Morena Zusso; Giuseppe Bruschetta; Daniela Impellizzeri; Salvatore Cuzzocrea; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.590

Review 6.  Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.

Authors:  Stephen D Skaper; Laura Facci
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 7.  Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2013-06-28       Impact factor: 5.590

Review 8.  Mast cells, glia and neuroinflammation: partners in crime?

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

9.  3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.

Authors:  Annalisa Fiasella; Andrea Nuzzi; Maria Summa; Andrea Armirotti; Glauco Tarozzo; Giorgio Tarzia; Marco Mor; Fabio Bertozzi; Tiziano Bandiera; Daniele Piomelli
Journal:  ChemMedChem       Date:  2014-05-14       Impact factor: 3.466

10.  Molecular mechanism of activation of the immunoregulatory amidase NAAA.

Authors:  Alexei Gorelik; Ahmad Gebai; Katalin Illes; Daniele Piomelli; Bhushan Nagar
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.